Review




Structured Review

BIOPAC acqknowledge waveform analysis function
Acqknowledge Waveform Analysis Function, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/waveform+data+acquisition+analysis+software+acqknowledge/pmc02290527-97-15-19
Average 90 stars, based on 1 article reviews
acqknowledge waveform analysis function - by Bioz Stars, 2026-10
90/100 stars

Images

Related Articles

Software:

Article Title: Brief pressure overload of the left ventricle reduces myocardial infarct size via activation of protein kinase C.
Article Snippet: Background: We have previously reported that brief pressure overload of the left ventricle reduced myocardial infarct (MI) size.. However, the role of protein kinase C (PKC) remains uncertain.. In this study, we investigated whether pressure overload reduces MI size by activating PKC.

Article Title: Exogenous GDF11 attenuates non-canonical TGF-β signaling to protect the heart from acute myocardial ischemia-reperfusion injury.
Article Snippet: Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor beta 1 (TGF-β1) superfamily that reverses age-related cardiac hypertrophy, improves muscle regeneration and angiogenesis, and maintains progenitor cells in injured tissue.. Recently, targeted myocardial delivery of the GDF11 gene in aged mice was found to reduce heart failure and enhance the proliferation of cardiac progenitor cells after myocardial ischemia–reperfusion (I–R).. No investigations have as yet explored the cardioprotective effect of exogenous recombinant GDF11 in acute I–R injury, despite the convenience of its clinical application.

Article Title: The role of adenosine in preconditioning by brief pressure overload in rats.
Article Snippet: A microtip-manometer (Millar, Houston, TX, USA) was inserted into the left ventricle to measure left ventricular pressure. .. Arterial pressure, heart rate, electrocardiography, and left ventricular pressure were recorded on a pressurized ink-chart recorder (Gould Instruments) and on a personal computer with a waveform data analysis software (AcqKnowledge; Biopac System, Goleta, CA, USA). ..

Article Title: Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk
Article Snippet: .. Changes in HR, BP, and ECG were simultaneously recorded using a personal computer with waveform analysis software (AcqKnowledge, Biopac System, Goleta, CA, United States) before and during the ischemia and reperfusion periods. ..

Article Title: Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling.
Article Snippet: Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling Yi-Hsin Wang, Ke-Min Chen, Ping-Sung Chiu, Shih-Chan Lai, HsingHui Su, Ming-Shiou Jan, Chia-Wei Lin, Dah-Yuu Lu, Yuan-Tsung Fu, Jiuan-Miaw Liao, Jinghua Tsai Chang, Shiang-Suo Huang PII: S0022-2828(16)30234-6 DOI: doi: 10.1016/j.yjmcc.2016.08.004 Reference: YJMCC 8430 To appear in: Journal of Molecular and Cellular Cardiology Received date: 1 December 2015 Revised date: 17 July 2016 Accepted date: 4 August 2016 Please cite this article as: Wang Yi-Hsin, Chen Ke-Min, Chiu Ping-Sung, Lai ShihChan, Su Hsing-Hui, Jan Ming-Shiou, Lin Chia-Wei, Lu Dah-Yuu, Fu Yuan-Tsung, Liao Jiuan-Miaw, Chang Jinghua Tsai, Huang Shiang-Suo, Lumbrokinase attenuates myocardial ischemia-reperfusion injury by inhibiting TLR4 signaling, Journal of Molecular and Cellular Cardiology (2016), doi: 10.1016/j.yjmcc.2016.08.004 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form.

Article Title: Association of the PPARγ/PI3K/Akt pathway with the cardioprotective effects of tacrolimus in myocardial ischemic/reperfusion injury.
Article Snippet: .. Heart rate, ventricular tachycardia and fibrillation were recorded in rats of I/R groups during I/R, or in the sham group rats at the corresponding time period via AcqKnowledge waveform analysis software (version 4.1; Biopac Systems, Inc., Goleta, CA, USA) based on diagnostic criteria from The Lambeth Conventions guidelines (25). ..

Diagnostic Assay:

Article Title: Association of the PPARγ/PI3K/Akt pathway with the cardioprotective effects of tacrolimus in myocardial ischemic/reperfusion injury.
Article Snippet: .. Heart rate, ventricular tachycardia and fibrillation were recorded in rats of I/R groups during I/R, or in the sham group rats at the corresponding time period via AcqKnowledge waveform analysis software (version 4.1; Biopac Systems, Inc., Goleta, CA, USA) based on diagnostic criteria from The Lambeth Conventions guidelines (25). ..



Similar Products

90
MicroStone Corporation waveform analysis software mvp-rf8-s
Waveform Analysis Software Mvp Rf8 S, supplied by MicroStone Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/inertial+sensor+mvp+rf8+bc/pm38599366-61-19-23
Average 90 stars, based on 1 article reviews
waveform analysis software mvp-rf8-s - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Hamamatsu waveform analysis software
Waveform Analysis Software, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/waveform+analysis+software/pmc11143964-271-6-10
Average 90 stars, based on 1 article reviews
waveform analysis software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Hamamatsu waveform analysis of cardiomyocyte software
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Waveform Analysis Of Cardiomyocyte Software, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/waveform+analysis+of+cardiomyocyte+software/pmc08369502-188-8-11
Average 90 stars, based on 1 article reviews
waveform analysis of cardiomyocyte software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
AtCor Medical arterial waveform analysis software with a validated generalized transfer function
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Arterial Waveform Analysis Software With A Validated Generalized Transfer Function, supplied by AtCor Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/arterial+waveform+analysis+software/pmc08385571-83-9-12
Average 90 stars, based on 1 article reviews
arterial waveform analysis software with a validated generalized transfer function - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Hamamatsu waveform analysis of cardiomyocyte software ver.1.2.1j
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Waveform Analysis Of Cardiomyocyte Software Ver.1.2.1j, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/video+capture+library+for+labview++ver+1+0++plug+in/pm34413773-242-18-24
Average 90 stars, based on 1 article reviews
waveform analysis of cardiomyocyte software ver.1.2.1j - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
wavemetrics inc waveform analysis software igor pro 8.03
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Waveform Analysis Software Igor Pro 8.03, supplied by wavemetrics inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/igor+pro+8/pmc07920032-84-5-11
Average 90 stars, based on 1 article reviews
waveform analysis software igor pro 8.03 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BIOPAC waveform analysis software acqknowledge
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Waveform Analysis Software Acqknowledge, supplied by BIOPAC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/waveform+data+acquisition+analysis+software+acqknowledge/pmc07858273-51-14-18
Average 90 stars, based on 1 article reviews
waveform analysis software acqknowledge - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Hamamatsu fdss waveform analysis software
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Fdss Waveform Analysis Software, supplied by Hamamatsu, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/fdss+waveform+analysis+software/pmc07840483-97-14-18
Average 90 stars, based on 1 article reviews
fdss waveform analysis software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Weisang GmbH waveform analysis software flex pro7.0
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Waveform Analysis Software Flex Pro7.0, supplied by Weisang GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/waveform+analysis+software+flex+pro7+0/pm32028775-64-5-10
Average 90 stars, based on 1 article reviews
waveform analysis software flex pro7.0 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ADInstruments waveform analysis software chart 5
Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC <t>2v-cardiomyocyte</t> in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.
Waveform Analysis Software Chart 5, supplied by ADInstruments, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/waveform+analysis+software/signal+processing+software+chart+4+2+3/pmc07331419-68-9-3
Average 90 stars, based on 1 article reviews
waveform analysis software chart 5 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.

Journal: Frontiers in Pharmacology

Article Title: High-Throughput Drug Screening System Based on Human Induced Pluripotent Stem Cell-Derived Atrial Myocytes ∼ A Novel Platform to Detect Cardiac Toxicity for Atrial Arrhythmias

doi: 10.3389/fphar.2021.680618

Figure Lengend Snippet: Cardiac differentiation from hiPSCs (A) Schematic of the protocol for the differentiation of cardiomyocytes from hiPS cells with (RA (+)) or without RA (RA (−)) treatment (B) The ratio of cardiomyocytes quantified by immunostaining with cardiac troponin-T (cTnT). The proportion of cTnT positive cells was 93.91 ± 2.51% in CT (control hiPS-CMs), or 96.79 ± 1.81% in AM (RA-treated hiPS-CMs), respectively (P = N.S.). Error bars represent SD of the mean from the values of independent experiments. n = 3. N.S., not significant (C) Immunofluorescence analysis of the percentage of MLC2a (atrial isoform) and MLC2v (ventricular isoform) positive expression in the CT and AM. Error bars represent SD of the mean from the values of independent experiments. ** p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in CT, ## p < 0.01 for comparison with MLC 2a+/MLC 2v-cardiomyocyte in AM, n = 3.

Article Snippet: Recording data were analyzed using Waveform Analysis of Cardiomyocyte Software (Ver.1.2.1J, Hamamatsu Photonics K.K.).

Techniques: Immunostaining, Control, Immunofluorescence, Expressing, Comparison